Trigeminal autonomic cephalalgias: Diagnostic and therapeutic developments

Current Opinion in Neurology

Volumn 21, Issue 3, 2008, Pages 323-330

  Goadsby, Peter J ^a,b   Cittadini, Elisabetta ^b   Burns, Brian ^b   Cohen, Anna S ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Cluster headache; Hemicrania continua; Paroxysmal hemicrania; SUNA; SUNCT

Indexed keywords

BETAMETHASONE; CYCLOOXYGENASE 2 INHIBITOR; ERGOTAMINE; GABAPENTIN; INDOMETACIN; LIDOCAINE; LITHIUM; METHYLPREDNISOLONE; PLACEBO; SUMATRIPTAN; TOPIRAMATE; VERAPAMIL; ZOLMITRIPTAN;

ALLODYNIA; BRAIN RADIOGRAPHY; CIRCADIAN RHYTHM; CLINICAL FEATURE; CLINICAL TRIAL; CLUSTER HEADACHE; CONSTIPATION; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DISEASE SEVERITY; DRUG INDUCED HEADACHE; DRUG USE; ECG ABNORMALITY; ENDOCRINE FUNCTION TEST; GINGIVA HYPERPLASIA; HEART BLOCK; HEMICRANIA CONTINUA; HUMAN; HYPOPHYSIS; LEG SWELLING; NERVE STIMULATION; OXYGEN THERAPY; PAROXYSMAL HEMICRANIA; PRIMARY HEADACHE; RECOMMENDED DRUG DOSE; REVIEW; SEX DIFFERENCE; SUNCT SYNDROME; TREATMENT RESPONSE; TRIGEMINAL AUTONOMIC CEPHALALGIA; TRIGEMINUS NEURALGIA;

ANALGESICS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PITUITARY DISEASES; SEROTONIN AGONISTS; TRIGEMINAL AUTONOMIC CEPHALALGIAS; TRYPTAMINES;

EID: 43249106250     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e3282fa6d76     Document Type: Review

References (111)

1. Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic features, including new cases. Brain 1997; 120:193-209.
2. Goadsby PJ, Cohen AS, Matharu MS. Trigeminal autonomic cephalalgias: diagnosis and treatment. Curr Neurol Neurosci Rep 2007; 7:117-125. Good general review of the TACs.
3. Headache Classification Committee of The International Headache Society. The International Classification of Headache Disorders (second edition). Cephalalgia 2004; 24(Suppl 1):1-160.
4. Cohen AS, Matharu MS, Goadsby PJ. Trigeminal autonomic cephalalgias: current and future treatments. Headache 2007; 47:969-980.
5. Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study in 230 patients with diagnostic implications. Neurology 2002; 58:354-361.
6. Cittadini E, Matharu MS, Goadsby PJ. Paroxysmal hemicrania: a prospective clinical study of thirty-one cases. Brain 2008; 131:1142-1155. Largest series of paroxysmal hemicrania patients from a single center so far described.
7. Cohen AS, Matharu MS, Goadsby PJ. Short-lasting Unilateral Neuralgiform Headache Attacks with Conjunctival injection and Tearing (SUNCT) or cranial Autonomic features (SUNA). A prospective clinical study of SUNCT and SUNA. Brain 2006; 129:2746-2760.
8. Cohen AS, Matharu MS, Goadsby PJ. Suggested guidelines for treating SUNCT and SUNA. Cephalalgia 2005; 25:1200.
9. Torelli P, Cologno D, Cademartiri C, Manzoni GC. Application of the International Headache Society classification criteria in 652 cluster headache patients. Cephalalgia 2001; 21:145-150.
10. Matharu MS, Boes CJ, Goadsby PJ. Management of trigeminal autonomic cephalalgias and hemicrania continua. Drugs 2003; 63:1637-1677.
11. Irimia P, Cittadini E, Paemeleire K, et al. Unilateral phonophobia and photophobia: a helpful symptom for the diagnosis of trigeminal autonomic cephalalgias (TACs) and hemicrania continua (HC). Cephalalgia 2005:856.
12. Zidverc-Trajkovic J, Pavlovic A, Mijajlovic M, et al. Cluster headache and paroxysmal hemicrania: differential diagnosis. Cephalalgia 2005; 25:244-248.
13. Antonaci F, Sjaastad O. Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations. Headache 1989; 29:648-656.
14. Ashkenazi A, Young WB. Dynamic mechanical (brush) allodynia in cluster headache. Headache 2004; 44:1010-1012.
15. Ladda J, Straube A, Forderreuther S, et al. Quantitative sensory testing in cluster headache: increased sensory thresholds. Cephalalgia 2006; 26:1043-1050.
16. Irimia P, Gallego-Perez Larraya J, Martinez-Vila E. Seasonal periodicity in SUNCT syndrome. Cephalalgia 2008; 28:94-96.
17. Levy M, Matharu MS, Meeran K, et al. The clinical characteristics of headache in patients with pituitary tumours. Brain 2005; 128:1921-1930.
18. Cohen AS, Goadsby PJ. Functional neuroimaging of primary headache disorders. Expert Rev Neurother 2006; 6:1159-1172.
19. Leone M, Partuno G, Vescovi A, Bussone G. Neuroendocrine dysfunction in cluster headache. Cephalalgia 1990; 10:235-239.
20. Favier I, van Vliet JA, Roon KI, et al. Trigeminal autonomic cephalgias due to structural lesions: a review of 31 cases. Arch Neurol 2007; 64:25-31. Important clinical information that suggests TAC patients should have adequate brain imaging.
21. Sjaastad O. Chronic paroxysmal hemicrania, hemicrania continua and SUNCT: the fate of the three first described cases. J Headache Pain 2006; 7:151-156.
22. Matharu MS, Levy MJ, Merry RT, Goadsby PJ. SUNCT syndrome secondary to prolactinoma. J Neurol Neurosurg Psychiatry 2003; 74:1590-1592.
23. Levy MJ, Matharu MS, Goadsby PJ. Prolactinomas, dopamine agonist and headache: two case reports. Eur J Neurol 2003; 10:169-174.
24. Monstad I, Krabbe A, Micieli G, et al. Preemptive oral treatment with sumatriptan during a cluster period. Headache 1995; 35:607-613.
25. Evers S, Bauer B, Suhr B. Ergotamine-induced headache associated with cluster headache. Neurology 1996; 46:291.
26. Hering-Hanit R. Alteration in nature of cluster headache during subcutaneous administration of sumatriptan. Headache 2000; 40:41-44.
27. Gobel H, Lindner A, Heinze A, et al. Acute therapy for cluster headache with sumatriptan: findings of a one year long-term study. Neurology 1998; 51:908-911.
28. Dousset V, Chrystome V, Ruiz B, et al. Does repeated subcutaneous administration of sumatriptan produce an unfavorable evolution in cluster headache? J Headache Pain 2004; 5:110-114.
29. Rossi P, Lorenzo GD, Formisano R, Buzzi MG. Subcutaneous sumatriptan induces changes in frequency pattern in cluster headache patients. Headache 2004; 44:713-718.
30. Hardebo JE. Subcutaneous sumatriptan in cluster headache: a time study in the effect of pain and autonomic symptoms. Headache 1993; 33:18-21.
31. Paemeleire K, Bahra A, Evers S, et al. Medication-overuse headache in cluster headache patients. Neurology 2006; 67:109-113.
32. Goadsby PJ. Is medication-overuse headache a distinct biological entity? Nat Clin Prac Neurol 2006; 2:401.
33. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular analgesic use? Headache 2003; 43:179-190.
34. Wilkinson SM, Becker WJ, Heine JA. Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 2001; 41:303-309.
35. Sjaastad O, Bakketeig LS. Cluster headache prevalence. Vaga study of headache epidemiology. Cephalalgia 2003; 23:528-533.
36. Evers S, Fischera M, May A, Berger K. Prevalence of cluster headache in Germany: results of the epidemiological DMKG study. J Neurol Neurosurg Psychiatry 2007; 78:1289-1290. New data on the epidemiology of cluster headache.
37. Ford HL, Gerry E, Johnson M, Williams R. A prospective study of the incidence, prevalence and mortality of multiple sclerosis in Leeds. J Neurol 2002; 249:260-265.
38. Ekbom K, Monstad I, Prusinski A, et al. Subcutaneous sumatriptan in the acute treatment of cluster headache: a dose comparison study. Acta Neurol Scand 1993; 88:63-69.
39. Ekbom K, The Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headache with sumatriptan. N Engl J Med 1991; 325:322-326.
40. Wendt J, Cady R, Singer R, et al. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults. Clin Ther 2006; 28:517-526.
41. van Vliet JA, Bahra A, Martin V, et al. Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology 2003; 60:630-633.
42. Cittadini E, May A, Straube A, et al. Effectiveness of intranasal zolmitriptan in acute cluster headache. A randomized, placebo-controlled, double-blind crossover study. Arch Neurol 2006; 63:1537-1542.
43. Rapoport AM, Mathew NT, Silberstein SD, et al. Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study. Neurology 2007; 69:821-826. New placebo-controlled study that shows zolmitriptan intranasal is effective in acute cluster headache.
44. Afridi SK, Shields KG, Bhola R, Goadsby PJ. Greater occipital nerve injection in primary headache syndromes: prolonged effects from a single injection. Pain 2006; 122:126-129.
45. Ambrosini A, Vandenheede M, Rossi P, et al. Suboccipital injection with a mixture of rapid- and long-acting steroids in cluster headache: a double-blind placebo-controlled study. Pain 2005; 118:92-96.
46. Busch V, Jakob W, Juergens T, et al. Functional connectivity between trigeminal and occipital nerves revealed by occipital nerve blockade and nociceptive blink reflexes. Cephalalgia 2006; 26:50-55.
47. Fogan L. Treatment of cluster headache: a double blind comparison of oxygen vs air inhalation. Arch Neurol 1985; 42:362-363.
48. Kudrow L. Response of cluster headache attacks to oxygen inhalation. Headache 1981; 21:1-4.
49. Cohen AS, Matharu MS, Burns B, Goadsby PJ. Randomized double-blind, placebo-controlled trial of high-flow inhaled oxygen in acute cluster headache. Cephalalgia 2007; 27:1188.
50. Gabai IJ, Spierings ELH. Prophylactic treatment of cluster headache with verapamil. Headache 1989; 29:167-168.
51. Leone M, D'Amico D, Frediani F, et al. Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo. Neurology 2000; 54:1382-1385.
52. Bussone G, Leone M, Peccarisi C, et al. Double blind comparison of lithium and verapamil in cluster headache prophylaxis. Headache 1990; 30:411-417.
53. Olesen J, Goadsby PJ. Cluster headache and related conditions. In: Olesen J, editor. Frontiers in headache research. vol. 9. Oxford: Oxford University Press; 1999.
54. Silberstein SD. Pharmacological management of cluster headache. CNS Drugs 1994; 2:199-207.
55. Singh BN, Nademanee K. Use of calcium antagonists for cardiac arrhythmias. Am J Cardiol 1987; 59:153B-162B.
56. Naylor WG. Calcium antagonists. London: Academic Press; 1988.
57. Cohen AS, Matharu MS, Goadsby PJ. Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy. Neurology 2007; 69:668-675. Very important paper for practical use of verapamil in cluster headache illustrating the need for regular ECG monitoring.
58. Matharu MS, van Vliet JA, Ferrari M, D., Goadsby PJ. Verapamil-induced gingival enlargement in cluster headache. J Neurol Neurosurg Psychiatry 2005; 76:124-127.
59. Goadsby PJ, Schoenen J, Ferrari MD, et al. Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia 2006; 26:1168-1170.
60. Mathew NT, Hurt W. Percutaneous radiofrequency trigeminal gangliorhizolysis in intractable cluster headache. Headache 1988; 28:328-331.
61. Kirkpatrick PJ, O'Brien M, MacCabe JJ. Trigeminal nerve section for chronic migrainous neuralgia. Br J Neurosurg 1993; 7:483-490.
62. Jarrar RG, Black DF, Dodick DW, Davis DH. Outcome of trigeminal nerve section in the treatment of chronic cluster headache. Neurology 2003; 60:1360-1362.
63. May A, Bahra A, Buchel C, et al. Hypothalamic activation in cluster headache attacks. Lancet 1998; 352:275-278.
64. Leone M. Deep brain stimulation in headache. Lancet Neurol 2006; 5:873-877.
65. Schoenen J, Di Clemente L, Vandenheede M, et al. Hypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action. Brain 2005; 128:940-947.
66. Bartsch T, Goadsby PJ. Anatomy and physiology of pain referral in primary and cervicogenic headache disorders. Headache Curr 2005; 2:42-48.
67. Matharu MS, Bartsch T, Ward N, et al. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain 2004; 127:220-230.
68. Burns B, Watkins L, Goadsby PJ. Successful treatment of medically intractable cluster headache using occipital nerve stimulation (ONS). Lancet 2007; 369:1099-1106. Potentially very important initial observations suggestion useful effects from occipital nerve stimulation in medically intractable chronic cluster headache.
69. Magis D, Allena M, Bolla M, et al. Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study. Lancet Neurol 2007; 6:314-321. Potentially very important initial observations suggest useful effects from occipital nerve stimulation in medically intractable chronic cluster headache.
70. Burns B, Watkins L, Goadsby PJ. Treatment of medically intractable cluster headache by occipital nerve stimulation: long term follow up 13 patients. Cephalalgia 2007; 27:1190.
71. Goadsby PJ. Neurostimulation in primary headache syndromes. Expert Rev Neurother 2007; 7:1785-1789.
72. Mathew NT, Kailasam J, Fischer A. Responsiveness to celecoxib in chronic paroxysmal hemicrania. Neurology 2000; 55:316.
73. Lisotto C, Maggioni F, Mainardi F, Zanchin G. Rofecoxib for the treatment of chronic paroxysmal hemicrania. Cephalalgia 2003; 23:318-320.
74. Siow HC. Seasonal episodic paroxysmal hemicrania responding to cyclooxygenase-2 inhibitors. Cephalalgia 2004; 24:414-415.
75. Moore RA, Derry S, Makinson GT, McQuay HJ. Tolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: systematic review and meta-analysis of information from company clinical trial reports. Arthritis Res Ther 2005; 7:R644-R665.
76. Camarda C, Camarda R, Monastero R. Chronic paroxysmal hemicrania and hemicrania continua responding to topiramate: two case reports. Clin Neurol Neurosurg 2008; 110:88-91.
77. Cohen AS, Goadsby PJ. Paroxysmal hemicrania responding to topiramate. J Neurol Neurosurg Psychiatry 2007; 78:96-97.
78. Pascual J, Quijano J. A case of chronic paroxysmal hemicrania responding to subcutaneous sumatriptan. J Neurol Neurosurg Psychiatry 1998; 65:407.
79. Dahlof C. Subcutaneous sumatriptan does not abort attacks of chronic paroxysmal hemicrania (CPH). Headache 1993; 33:201-202.
80. Goadsby PJ, Matharu MS, Boes CJ. SUNCT syndrome or trigeminal neuralgia with lacrimation. Cephalalgia 2001; 21:82-83.
81. Pareja JA, Kruszewski P, Sjaastad O. SUNCT syndrome: trials of drugs and anesthetic blockades. Headache 1995; 35:138-142.
82. D'Andrea G, Granella F, Cadaldini M. Possible usefulness of lamotrigine in the treatment of SUNCT syndrome. Neurology 1999; 53:1609.
83. Leone M, Rigamonti A, Usai S, et al. Two new SUNCT cases responsive to lamotrigine. Cephalalgia 2000; 20:845-847.
84. D'Andrea G, Granella F, Ghiotto N, Nappi G. Lamotrigine in the treatment of SUNCT syndrome. Neurology 2001; 57:1723-1725.
85. Gutierrez-Garcia JM. SUNCT syndrome responsive to lamotrigine. Headache 2002; 42:823-825.
86. Chakravarty A, Mukherjee A. SUNCT syndrome responsive to lamotrigine: documentation of the first Indian case. Cephalalgia 2003; 23:474-475.
87. Piovesan EJ, Siow C, Kowacs PA, Werneck LC. Influence of lamotrigine over the SUNCT syndrome: one patient follow-up for two years. Arq Neuropsiquiatr 2003; 61:691-694.
88. Malik K, Rizvi S, Vaillancourt PD. The SUNCT syndrome: successfully treated with lamotrigine. Pain Med 2002; 3:167-168.
89. Matharu MS, Boes CJ, Goadsby PJ. SUNCT syndrome: prolonged attacks, refractoriness and response to topiramate. Neurology 2002; 58:1307.
90. Rossi P, Cesarino F, Faroni J, et al. SUNCT syndrome successfully treated with topiramate: case reports. Cephalalgia 2003; 23:998-1000.
91. Hunt CH, Dodick DW, Bosch P. SUNCT responsive to gabapentin. Headache 2002; 42:525-526.
92. Porta-Etessam J, Benito-Leon J, Martinez-Salio A, Berbel A. Gabapentin in the treatment of SUNCT syndrome. Headache 2002; 42:523-524.
93. Graff-Radford SB. SUNCT syndrome responsive to gabapentin. Cephalalgia 2000; 20:515-517.
94. Cohen A, Matharu MS, Goadsby PJ. Double-blind placebo-controlled trial of topiramate in SUNCT. Cephalalgia 2007; 27:758.
95. Medina JL, Diamond S. Cluster headache variant: spectrum of a new headache syndrome. Arch Neurol 1981; 38:705-709.
96. Sjaastad O, Spierings EL. Hemicrania continua: another headache absolutely responsive to indomethacin. Cephalalgia 1984; 4:65-70.
97. Peres MFP, Silberstein SD, Nahmias S, et al. Hemicrania continua is not that rare. Neurology 2001; 57:948-951.
98. Wheeler SD, Allen KF, Pusey T. Is hemicrania continua a migraine variant? Cephalalgia 2001; 21:508.
99. Pasquier F, Leys D, Petit H. Hemicrania continua: the first bilateral case. Cephalalgia 1987; 7:169-170.
100. Iordanidis T, Sjaastad O. Hemicrania continua: a case report. Cephalalgia 1989; 9:301-303.
101. Trucco M, Antonaci F, Sandrini G. Hemicrania continua: a case responsive to piroxicam-beta-cyclodextrin. Headache 1992; 32:39-40.
102. Newman LC, Lipton RB, Russell M, Solomon S. Hemicrania continua: attacks may alternate sides. Headache 1992; 32:237-238.
103. Bordini C, Antonaci F, Stovner LJ, et al. Hemicrania continua: a clinical review. Headache 1991; 31:20-26.
104. Newman LC, Lipton RB, Solomon S. Hemicrania continua: ten new cases and a review of the literature. Neurology 1994; 44:2111-2114.
105. Peres MFP, Siow HC, Rozen TD. Hemicrania continua with aura. Cephalalgia 2002; 22:246-248.
106. Peres MFP, Zukerman E. Hemicrania continua responsive to rofecoxib. Cephalalgia 2000; 20:130-131.
107. Brighina F, Palermo A, Cosentino G, Fierro B. Prophylaxis of hemicrania continua: two new cases effectively treated with topiramate. Headache 2007; 47:441-443.
108. Matharu MS, Bradbury P, Swash M. Hemicrania continua: side alternation and response to topiramate. Cephalalgia 2006; 26:341-344.
109. Schwedt T, Dodick D, Trentman T, Zimmerman R. Occipital nerve stimulation for chronic cluster headache and hemicrania continua: pain relief and persistence of autonomic features. Cephalalgia 2006; 26:1025-1027.
110. May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiological implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cerebral Blood Flow Metab 1999; 19:115-127.
111. Obermann M, Yoon M-S, Dommes P, et al. Prevalence of trigeminal autonomic symptoms in migraine: a population-based study. Cephalalgia 2007; 27:504-509. Important clinical paper reporting how common cranial autonomic features are in migraine.